Deloitte survey: More Americans forgo medical care due to cost
WASHINGTON With unemployment rates remaining at an all-time high, 1-in-5 Americans chose not to seek medical care for a recent illness or injury, with 4-out-of-10 citing cost as the primary factor, according to a Deloitte Center for Health Solutions survey of more than 4,000 adults in the United States released Wednesday.
Deloitte’s survey also revealed a decline in the number of consumers reporting to have visited a physician or healthcare professional in the past year; 79% of respondents sought medical attention in 2010 as compared with 85% who did likewise in 2009.
"As the burden of care continues to be shifted to the individual, and more Americans lose their jobs and their health insurance, we expect this trend will continue," stated Paul Keckley executive director, Deloitte Center for Health Solutions. "It will be interesting to see what happens in 2014 when the individual mandates requiring Americans to purchase health insurance kick in. Will we see a significant spike in visits to the doctor as more Americans join the ranks of the insured?"
Below are some of the alternative options to traditional care that consumers are exploring according to the survey:
- 15% of consumers reported visiting a retail clinic and 34% said they would do so if it cost 50% or less than the cost of a doctor’s appointment;
- More consumers are seeking alternative or natural remedies before seeing a physician (17% chose this option in 2010 compared with 12% in 2009); and
- More consumers are supplementing their current regimes with alternative remedies (20% pursued this route in 2010 compared with 16% in 2009).
"As consumers increasingly begin to ‘shop’ for their care, they are seeking new options — price and convenience are key drivers," added Keckley. "Some consumers are heading to retail clinics for their flu shot instead of the doctor’s office."
Some healthcare organizations have reported a decline in utilization of healthcare services in their most recent quarterly earnings reports. Reasons attributed include declines in admissions at some hospitals, decreases in visits to the doctor, less volume for some prescriptions and, in some cases, a reduction in medical tests ordered.
"While some healthcare organizations are seeing a dip in utilization, this is not the case across the board," said Russ Rudish, vice chairman and Deloitte healthcare provider practice leader. "In fact, some hospitals and healthcare providers have also reported increased demand for healthcare services. A lot depends on geography and patient population. Overall, the healthcare provider industry is cautiously optimistic that once deductibles are hit and health insurance kicks in, the volume of activity for medical services may return."
Anationally representative sample of 4,008 U.S. consumers ages 18 years and older were surveyed between Dec. 28, 2009 and Jan. 5, 2010, as part of Deloitte’s third annual study examining healthcare consumers’ attitudes, behaviors and unmet needs conducted by the Deloitte Center for Health Solutions. The results were weighted to assure proper proportional representation to the nation’s population.
Drugstore.com extends partnership with Medco Health Solutions
BELLEVUE, Wash. Drugstore.com on Tuesday announced the extension through 2018 of its strategic alliance with Medco Health Solutions.
In 2008, Medco launched its Medco Health Store — an online retail destination offering a wide range of non-prescription consumer health products, including over-the-counter medicines. Drugstore.com supplied technical and operational support for this launch, including fulfillment, distribution and customer care for the Medco-branded online store. Today, the Medco Health Store has grown to include more than 1.4 million registered members.
“Our partnership strategy is a key driver of Drugstore.com’s growth and leverages our leadership in online merchandising and fulfillment in the health and beauty category,” stated Dawn Lepore, CEO and chairman of Drugstore.com. “Medco is a leader in the healthcare and pharmacy industries and we are excited to be extending this relationship.”
“Medco’s partnership with Drugstore.com has enhanced the comprehensive healthcare and pharmacy services we deliver to our clients and their members,” added Tom Moriarty, general counsel, secretary, and SVP, pharmaceutical strategies and solutions, Medco Health Solutions.
In addition to extending the term of the relationship, the economic arrangement between Drugstore.com and Medco has changed, giving Medco more flexibility in pricing and promotions.
Pfizer’s Q2 sales get boost from specialty drugs
NEW YORK Pfizer had a big increase in sales and a modest increase in profits during second quarter 2010, according to a financial statement released Tuesday.
The world’s largest drug maker had $17.3 billion in sales and $2.5 billion in profits, compared with $11 billion in sales and $2.3 billion in profits in second quarter 2009, representing respective increases of 58% and 9%.
The increase in sales included a 165% increase in sales of specialty drugs, from $1.4 billion in second quarter 2009 to $3.8 billion this quarter, stemming from Pfizer’s purchase of Wyeth. Cancer drug sales decreased by 2%, from $355 million to $349 million, while primary care drugs increased from $5.2 billion to $5.9 billion, and established products increased from $1.7 billion to $2.7 billion. Biotech drug sales increased from $10 billion to $15 billion.